AH5N1 prepandemic influenza vaccine (Vepacel®): A guide to its use

BioDrugs

Volumn 26, Issue 6, 2012, Pages 425-430

  Keating, Gillian M ^a   Plosker, Greg L ^a   Lyseng Williamson, Katherine A ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Clinical Q and A; Influenza A virus vaccine H5N1, general; Influenza A virus infections

Indexed keywords

INFLUENZA VACCINE;

ACTIVE IMMUNIZATION; ARTHRALGIA; CELLULAR IMMUNITY; CHILL; DISEASE TRANSMISSION; DRUG TOLERABILITY; FATIGUE; FEVER; HEADACHE; HERPES ZOSTER; HUMAN; HYPERHIDROSIS; IMMUNOGENICITY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; INJECTION SITE PAIN; MALAISE; MYALGIA; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVIEW; RHINOPHARYNGITIS; SORE THROAT; TREATMENT INDICATION; ANIMAL; CERCOPITHECUS; CLINICAL TRIAL (TOPIC); IMMUNOLOGY; INFLUENZA; PANDEMIC; PRACTICE GUIDELINE; VERO CELL; VIRION;

ANIMALS; CERCOPITHECUS AETHIOPS; CLINICAL TRIALS AS TOPIC; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; PRACTICE GUIDELINES AS TOPIC; VERO CELLS; VIRION;

EID: 84868093799     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11209740-000000000-00000     Document Type: Review

References (15)

1. World Health Organization. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits [online]. Available from URL: http://whqlibdoc.who.int/publications/2011/ 9789241503082-eng.pdf [Accessed 2012 May 3]
2. World Health Organization. Pandemic influenza preparedness and response: A WHO guidance document [online]. Available from URL: http://whqlibdoc. who.int/publications/2009/9789241547680-eng.pdf [Accessed 2012 May 2]
3. Jennings LC, Monto AS, Chan PK, et al. Stockpiling prepandemic influenza vaccines: A new cornerstone of pandemic preparedness plans. Lancet Infect Dis 2008 October; 8 (10): 650-8
4. Wright PF. Vaccine preparedness: Are we ready for the next influenza pandemic? N Engl J Med 2008 12 Jun; 358 (24): 2540-3 (Pubitemid 351831355)
5. Ferguson NM, Cummings DA, Fraser C, et al. Strategies for mitigating an influenza pandemic. Nature 2006 Jul 27; 442 (7101): 448-52 (Pubitemid 44264793)
6. Plosker GL. A/H5N1 Prepandemic influenza vaccine (whole virion, Vero cellderived, inactivated) [Vepacel-]. Drugs 2012; 72 (11): 1543-57
7. Kistner O, Barrett PN, Mundt W, et al. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 1998 May/Jun; 16 (9-10): 960-8 (Pubitemid 28276008)
8. Barrett PN, Mundt W, Kistner O, et al. Vero cell platform in vaccine production: Moving towards cell culture-based viral vaccines. Expert Rev Vaccines 2009 May; 8 (5): 607-18
9. Vepacel suspension for injection: Summary of product characteristics. London: European Medicines Agency, 2012 Mar 16
10. European Medicines Agency. Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96) [online]. Available from URL: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific -guideline/2009/09/WC500003945.pdf [Accessed 2012 Apr 10]
11. European Medicines Agency. Assessment report Vepacel A/H5N1 prepandemic influenza vaccine (whole virion, Vero cell derived, inactivated) [Procedure No. EMEA/H/C/002089; online]. Available from URL: http:// www.ema.europa.eu/docs/en- GB/document-library/EPAR-Public-assess ment-report/human/002089/WC500124225.pdf [Accessed 2012 Apr 10]
12. Ehrlich HJ, Muller M, Oh HML, et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008 Jun 12; 358 (24): 2573-84 (Pubitemid 351831358)
13. Ehrlich HJ, Muller M, Fritsch S, et al. A cell culture (Vero)-derive whole-virus vaccine induces cross-reactive memory responses. J Infect Dis 2009 Oct 1; 200 (7): 1113-8
14. Crowe BA, Brü hl P, Gerencer M, et al. Evaluation of the cellular immune responses induced by a non-Adjuvanted inactivated whole virus A/H5N1 VN/1203 pandemic influenza vaccine in humans. Vaccine 2010; 29 (2): 166-73
15. van der Velden MV, Aichinger G, Pö llabauer EM, et al. Cell culture (Vero cell) derived whole-virus non-Adjuvanted H5N1 influenza vaccine induces longlasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming. Vaccine 2012; 30 (43): 6127-35